Baiyunshan Pharma Gets China Supplemental Drug Nod for Nitroglycerin Injection for Heart Problems
Baiyunshan Pharma Gets China Supplemental Drug Nod for Nitroglycerin Injection for Heart Problems
白雲山製藥公司獲得中國檢疫部門批准，用於心臟問題的硝酸甘油注射劑的補充藥物許可
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊